JPS6332766B2 - - Google Patents
Info
- Publication number
- JPS6332766B2 JPS6332766B2 JP54154147A JP15414779A JPS6332766B2 JP S6332766 B2 JPS6332766 B2 JP S6332766B2 JP 54154147 A JP54154147 A JP 54154147A JP 15414779 A JP15414779 A JP 15414779A JP S6332766 B2 JPS6332766 B2 JP S6332766B2
- Authority
- JP
- Japan
- Prior art keywords
- ion
- ions
- composition
- sodium
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 32
- 235000013361 beverage Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 6
- 239000008121 dextrose Substances 0.000 claims 6
- 229960001031 glucose Drugs 0.000 claims 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 229960005070 ascorbic acid Drugs 0.000 claims 4
- 235000010323 ascorbic acid Nutrition 0.000 claims 4
- 239000011668 ascorbic acid Substances 0.000 claims 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 3
- 235000005979 Citrus limon Nutrition 0.000 claims 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 3
- 229910001425 magnesium ion Inorganic materials 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 3
- 239000001103 potassium chloride Substances 0.000 claims 3
- 235000011164 potassium chloride Nutrition 0.000 claims 3
- 229910001414 potassium ion Inorganic materials 0.000 claims 3
- 229910001415 sodium ion Inorganic materials 0.000 claims 3
- 244000248349 Citrus limon Species 0.000 claims 2
- LVXHNCUCBXIIPE-UHFFFAOYSA-L disodium;hydrogen phosphate;hydrate Chemical compound O.[Na+].[Na+].OP([O-])([O-])=O LVXHNCUCBXIIPE-UHFFFAOYSA-L 0.000 claims 2
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000013355 food flavoring agent Nutrition 0.000 claims 2
- 229940085991 phosphate ion Drugs 0.000 claims 2
- 235000008160 pyridoxine Nutrition 0.000 claims 2
- 239000011677 pyridoxine Substances 0.000 claims 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000001509 sodium citrate Substances 0.000 claims 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 2
- BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 claims 2
- 229940011671 vitamin b6 Drugs 0.000 claims 2
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims 1
- 239000008122 artificial sweetener Substances 0.000 claims 1
- 235000021311 artificial sweeteners Nutrition 0.000 claims 1
- 229940086763 ascorbic acid 100 mg Drugs 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 1
- 235000019341 magnesium sulphate Nutrition 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 229940059932 pyridoxine 25 mg Drugs 0.000 claims 1
- 229960001790 sodium citrate Drugs 0.000 claims 1
- 235000011083 sodium citrates Nutrition 0.000 claims 1
- -1 sutucarose Chemical compound 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 17
- 238000009472 formulation Methods 0.000 description 14
- 239000003792 electrolyte Substances 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000002489 hematologic effect Effects 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010027423 Metabolic alkalosis Diseases 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 238000009535 clinical urine test Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU707778 | 1978-12-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5581575A JPS5581575A (en) | 1980-06-19 |
| JPS6332766B2 true JPS6332766B2 (enrdf_load_stackoverflow) | 1988-07-01 |
Family
ID=3697684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15414779A Granted JPS5581575A (en) | 1978-12-11 | 1979-11-27 | Electrolyte drinks |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5581575A (enrdf_load_stackoverflow) |
| AU (1) | AU526503B2 (enrdf_load_stackoverflow) |
| GB (1) | GB2037565B (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0256579U (enrdf_load_stackoverflow) * | 1988-10-19 | 1990-04-24 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH634203A5 (de) * | 1982-01-12 | 1983-01-31 | Haigis Erich Mathias | Getraenk fuer mensch und tier. |
| US4551342A (en) * | 1983-02-01 | 1985-11-05 | The Procter & Gamble Company | Beverages containing specific cation-edible acid mixtures for improved flavor impression |
| CH644737A5 (de) * | 1983-10-10 | 1984-08-31 | Baltensperger E Natrex Diaetet | Getraenk mit einem hohen gehalt an magnesium. |
| DE181988T1 (de) * | 1984-11-23 | 1986-11-27 | Aktiebolaget Pripps Bryggerier, Bromma | Produkt fuer getraenke. |
| FI89761C (fi) * | 1986-10-16 | 1993-11-25 | Sinebrychoff Ab | Anvaendning av aeppelsyra foer framstaellning av motionsdryckpulver |
| US4994283A (en) * | 1987-07-02 | 1991-02-19 | The Procter & Gamble Company | Iron-calcium mineral supplements with enhanced bioavailability |
| DE68903147T2 (de) * | 1988-07-29 | 1993-04-01 | Univ Florida | Zusammensetzungen und verfahren zum erlangen einer verbesserten physiologischen reaktion bei leibesuebungen. |
| US5032411A (en) * | 1990-02-27 | 1991-07-16 | University Of Texas System Board Of Regents | Beverage compositions for human consumption |
| US6197329B1 (en) * | 1999-05-03 | 2001-03-06 | Drugtech Corporation | Anti-nausea compositions and methods |
| US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
| JP7211880B2 (ja) * | 2019-04-12 | 2023-01-24 | サントリーホールディングス株式会社 | ナトリウム、カリウム、及びアスコルビン酸を含有する飲料 |
| JP7211879B2 (ja) * | 2019-04-12 | 2023-01-24 | サントリーホールディングス株式会社 | ナトリウム及びグルコン酸を含有する飲料 |
| JP7211881B2 (ja) * | 2019-04-12 | 2023-01-24 | サントリーホールディングス株式会社 | ナトリウム、カリウム、及びクエン酸を含有する飲料 |
| WO2020209300A1 (ja) * | 2019-04-12 | 2020-10-15 | サントリーホールディングス株式会社 | ナトリウム及び有機酸を含有する飲料 |
| US20230363423A1 (en) * | 2020-09-25 | 2023-11-16 | Abbott Laboratories | Ready-to-drink carbonated electrolyte beverage |
-
1978
- 1978-12-11 AU AU52035/79A patent/AU526503B2/en not_active Ceased
-
1979
- 1979-11-27 JP JP15414779A patent/JPS5581575A/ja active Granted
- 1979-11-30 GB GB7941451A patent/GB2037565B/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0256579U (enrdf_load_stackoverflow) * | 1988-10-19 | 1990-04-24 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5203579A (en) | 1980-06-19 |
| JPS5581575A (en) | 1980-06-19 |
| GB2037565B (en) | 1983-03-23 |
| GB2037565A (en) | 1980-07-16 |
| AU526503B2 (en) | 1983-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6332766B2 (enrdf_load_stackoverflow) | ||
| Clancy et al. | Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players | |
| Kreider et al. | Effects of creatine supplementation on body composition, strength, and sprint performance | |
| Córdova et al. | Effect of training on zinc metabolism: changes in serum and sweat zinc concentrations in sportsmen | |
| Welle et al. | Myofibrillar protein synthesis in young and old human subjects after three months of resistance training | |
| Scrimshaw | Functional consequences of iron deficiency in human populations | |
| Lexell et al. | Heavy‐resistance training in older Scandinavian men and women: short‐and long‐term effects on arm and leg muscles | |
| Calloway et al. | Energy requirements and energy expenditure of elderly men | |
| Cristaldi et al. | Tolerance of inorganic selenium in wether sheep | |
| Walberg | Aerobic exercise and resistance weight-training during weight reduction: Implications for obese persons and athletes | |
| Simmer et al. | Nutritional rehabilitation in Bangladesh—the importance of zinc | |
| Shephard et al. | Vitamin E, exercise, and the recovery from physical activity | |
| Greger et al. | Effect of zinc supplementation on taste acuity of the aged | |
| Oscai et al. | Detailed body composition analysis on female rats subjected to a program of swimming | |
| KR20180029963A (ko) | 아미노산 보충제 | |
| Weaver et al. | Bioavailability of calcium from tofu as compared with milk in premenopausal women | |
| Aedma et al. | Dietary sodium citrate supplementation does not improve upper-body anaerobic performance in trained wrestlers in simulated competition-day conditions | |
| Roodenburg | Iron supplementation during pregnancy | |
| Sauberlich et al. | Ascorbic acid and erythorbic acid metabolism in nonpregnant women | |
| WARREN et al. | The effect of dietary fibre on hydration status after dehydration with frusemide | |
| Dutra de Oliveira et al. | Iron fortification of domestic drinking water to prevent anemia among low socioeconomic families in Brazil | |
| Anschuetz et al. | Meal composition and iron status of experienced male and female distance runners | |
| Rhode et al. | Effect of orange juice, folic acid, and oral contraceptives on serum folate in women taking a folate-restricted diet. | |
| Golden | Zinc in cell division and tissue growth: physiological aspects | |
| Spodaryk et al. | Relationship among reduced level of stored iron and dietary iron in trained women |